Nonprofit group Myelin Repair Foundation is preparing to present major research work to biotech firms that are already involved in multiple sclerosis, such as Eli Lilly and Co., Biogen Idec, Novartis AG and Genentech. The foundation's scientists have discovered a potential method to prevent T-cells from attacking myelin.

Related Summaries